Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Non-Current Debt (2020 - 2025)

MDxHealth (MDXH) has disclosed Non-Current Debt for 6 consecutive years, with $25.8 million as the latest value for Q4 2025.

  • Quarterly Non-Current Debt fell 37.73% to $25.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $25.8 million through Dec 2025, down 37.73% year-over-year, with the annual reading at $25.8 million for FY2025, 37.73% down from the prior year.
  • Non-Current Debt hit $25.8 million in Q4 2025 for MDxHealth, down from $41.4 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $63.3 million in Q4 2023 to a low of $1.5 million in Q4 2021.
  • Historically, Non-Current Debt has averaged $37.1 million across 5 years, with a median of $41.4 million in 2024.
  • Biggest five-year swings in Non-Current Debt: skyrocketed 3551.91% in 2022 and later tumbled 37.73% in 2025.
  • Year by year, Non-Current Debt stood at $1.5 million in 2021, then surged by 3551.91% to $53.5 million in 2022, then grew by 18.16% to $63.3 million in 2023, then crashed by 34.48% to $41.4 million in 2024, then crashed by 37.73% to $25.8 million in 2025.
  • Business Quant data shows Non-Current Debt for MDXH at $25.8 million in Q4 2025, $41.4 million in Q4 2024, and $63.3 million in Q4 2023.